Speaker: Sara Hughes, GSK
Preparing individual patient data from clinical trials for sharing: the GlaxoSmithKline approach
Co-authors: Karen Wells, Paul McSorley and Andrew Freeman;
Pharmaceutical Statistics, Volume 13, Issue 3, Pages 179-183, May/June 2014 Abstract | Paper+ | Slides
Speaker: Kert Viele, Berry Consultants
Use of historical control data for assessing treatment effects in clinical trials
Co-authors: Scott Berry, Beat Neuenschwander, Billy Amzal, Fang Chen, Nathan Enas, Brian Hobbs, Joseph G. Ibrahim, Nelson Kinnersley, Stacy Lindborg, Sandrine Micallef, Satrajit Roychoudhury and Laura Thompson;
Pharmaceutical Statistics, Volume 13, Issue 1, Pages 41–54, January/February 2014 Abstract
| Paper+ | Slides
+ Papers available to view from 10th July 2014 to 7th August 2014.
For a flier advertising the event, please click here.
Joint PSI, EFSPI & ASA BIOP Webinar: Estimands
PSI, the European Federation of Statisticians in the Pharmaceutical Industry (EFSPI) and the Biopharmaceutical Section of the American Statistical Association (ASA) are jointly organising a webinar on Estimands in Practice. Speakers from regulatory authorities (FDA and EMA) and industry will present on their experience on this topic to date.
Discover your potential by working as a Covance Senior Principal / Principal Biostatistician. You'll enjoy a varied role working for different sponsors across several therapeutic areas, leading projects and mentoring junior members of the department.
Biometrics at AstraZeneca provides the data that influences decisions on how we roll back the frontiers of science to bring life-changing medicines to the world. We are at the heart of design, analytics and interpretation of AstraZeneca’s portfolio.